Company News in the Life Science Industry

»

Reset 

SINOMED® Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent

TIANJIN, China, July 13, 2020 /PRNewswire/ -- SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed,... Read more ››

By: PR Newswire Association LLC. - 13 Jul 2020
Related companies:  Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) | Sino Biological Inc

PQE Group Creates an Internal Research Task Force to Fight Fake News in Relation to COVID-19

FLORENCE, Italy, July 13, 2020 /CNW/ -- With the pandemic caused by COVID-19, the continuous need to obtain information has pushed people to rely on unreliable sources, thus fomenting the spread of fake news.

Read more ››
By: PR Newswire Association LLC. - 13 Jul 2020

Hernia Repair Devices and Consumables Market to Reach $6.35 Bn, Globally, by 2027 at 3.6% CAGR: AMR

- Rise in advanced meshes demand, surge in implementation of robotic surgeries, and increase in number of hernia patients drive the global hernia repair devices and consumables market

Read more ››
By: PR Newswire Association LLC. - 13 Jul 2020
Related companies:  Allied Market Research

Implantable Loop Recorders Market Size Worth $2.1 Billion by 2027: Grand View Research, Inc.

SAN FRANCISCO, July 13, 2020 /PRNewswire/ -- The global Read more ››

By: PR Newswire Association LLC. - 13 Jul 2020

New Compounding Pharmacy Website - a Lifeline for Many During COVID-19

BERKELEY, Calif., July 13, 2020 /PRNewswire/ -- As early as last week COVID-19 has continued to surge throughout many states, including California, Georgia, and Hawaii. According to the CDC, over 2.6 million cases have been reported and a total of 127,299 deaths. In addition, the COVID-19 crisis... Read more ››

By: PR Newswire Association LLC. - 13 Jul 2020

Roche provides update on Phase III study of Tecentriq in women with advanced stage ovarian cancer

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Kiadis appoints Ray Barlow, Ph.D. as Chief Business Officer and Govert Schouten, Ph.D. as Head of Innovation to Kiadis Management Team

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  Kiadis Pharma N.V.

New data from phase IIIb study reinforces safety profile of Roche’s Hemlibra in people with haemophilia A

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Sales of Cardio-Cerebrovascular Products and Lianhua Qingwen Surge, Yiling Pharmaceutical Predicting a 50% Increase in Half-year Net Profit

SHIJIAZHUANG, China, July 13, 2020 /PRNewswire/ -- In the evening of July 12, Yiling Pharmaceutical released the performance forecast for the first half year. In the first half of this year, the company achieved a net profit attributable to shareholders of 682 million to 728 million Yuan (USD... Read more ››

By: PR Newswire Association LLC. - 13 Jul 2020
Related companies:  Shijiazhuang Yiling Pharmaceutical Co.,Ltd.

Amgen Announces Additional Investment In BeiGene

THOUSAND OAKS, Calif., July 12, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares, which maintains Amgen's current pro rata ownership of BeiGene at approximately 20.3%. This... Read more ››

By: PR Newswire Association LLC. - 13 Jul 2020
Related companies:  Amgen, Inc.

BeiGene Announces Pricing of Approximately $2.08 Billion Registered Direct Offering

Read more ››
By: GlobenewsWire - 13 Jul 2020
Related companies:  BeiGene, Ltd.

Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016 in China

Read more ››
By: GlobenewsWire - 13 Jul 2020

Antengene Appoints Former Celgene ANZ Medical Leader Dirk Hoenemann as Head of Medical Affairs in Asia Pacific Region & Early Clinical Development

SHANGHAI and MELBOURNE, Australia, July 13, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced the appointment of Dirk Hoenemann, M.D as VP, Head of Medical Affairs for Asia Pacific Region (APAC) and Early Clinical Development. He will report directly to Mr. Thomas Karalis,... Read more ››

By: PR Newswire Association LLC. - 13 Jul 2020
Related companies:  Antengene Corporation

Translated Tool from NCCN Measures Mental Health "Temperature" of People with Cancer

PLYMOUTH MEETING, Pennsylvania, July 13, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network(®) (NCCN(®))--an alliance of Read more ››

By: PR Newswire Association LLC. - 13 Jul 2020

Junshi Biosciences Announces Approval of “B” Marker Removal from Company’s Stock Name by HKEX

Read more ››
By: GlobenewsWire - 12 Jul 2020

AMAG Announces Presentation of Ciraparantag Data at the International Society on Thrombosis and Haemostasis

Read more ››
By: GlobenewsWire - 12 Jul 2020
Related companies:  AMAG Pharmaceuticals, Inc.

Early Publication of Essity's Half-year Report 2020

STOCKHOLM, Sweden, July 12, 2020 /PRNewswire/ -- Essity's Half-year Report for 2020 will be published on Monday, July 13 at approximately 7:00 a.m. CET instead of Friday, July 17 as previously communicated. The reason for the earlier publishing date is the uncertainty entailed by the ongoing... Read more ››

By: PR Newswire Association LLC. - 12 Jul 2020

Samsung Biologics signs additional development and manufacturing agreement with STCube

SONGDO, South Korea, July 11, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has further expanded its partnership with STCube through an additional development and manufacturing service agreement of STM418, an anti-PD1 immuno-oncology candidate.

Read more ››
By: PR Newswire Association LLC. - 12 Jul 2020
Related companies:  Samsung Biologics Co., Ltd. | STCube Pharmaceuticals, Inc. | STCube, Inc.

United Imaging Announces New Technology That Advances Molecular Imaging, Hints at a Series of New Announcements

HOUSTON, July 11, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, continues to set a new standard in molecular imaging and redefine nuclear medicine. The company has begun unveiling new technology that showcases more of its all-digital... Read more ››

By: PR Newswire Association LLC. - 11 Jul 2020

World's First FDA IDE Coronary Patient Treated With a DEB

NYON, Switzerland, July 11, 2020 /PRNewswire/ -- MedAlliance has announced enrollment of the first patient in its study of SELUTION SLR™ 014 DEB for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the... Read more ››

By: PR Newswire Association LLC. - 11 Jul 2020
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies